Sign inJoin waitlistJoin the waitlist

Julio Barredo

Toppel Family Endowed Chair and Director, Division of Pediatric Hematology- Oncology · Jackson Memorial Hospital

Credentials: · · · ·

History

Pediatric Hematology & Oncology Division · University of Miami/Jackson Health System
Present
University of Miami/Jackson Health System
Present
University of Miami/Jackson Health System
Present

Pediatric Hematology-Oncology
Children's Hospital Los Angeles
1985–1986
Pediatrics
SUNY Downstate Health Sciences University
1982–1985
UNIV NACIONAL MAYOR DE SAN MARCOS, LIMA
1978–1982

Research

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
The Lancet · 2011 · 637 citations
A dideazatetrahydrofolate analogue lacking a chiral center at C-6, N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5- yl)ethyl]benzoyl]-L-glutamic acid, is an…
Journal of Medicinal Chemistry · 1992 · 208 citations
All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders
Blood · 1997 · 175 citations

Joseph Laver
12 papers
MA
Miguel Abboud
12 papers
AR
Arthur Ritchey
6 papers
Naomi Winick
4 papers
UY
Usman Yusuf
4 papers
BC
Bruce Camitta
3 papers
JC
James Casella
3 papers
RI
Rathi Iyer
3 papers
Stephen Hunger
3 papers
William Carroll
3 papers
Winfred Wang
3 papers
Abdullah Kutlar
2 papers

Grants

Molecular Determinants of Methotrexate in Acute Lymphoblastic Leukemia
National Cancer Institute · R01
Contact PI · $1.5M · University of Miami School of Medicine
2004–2011
Pediatric Hydroxyurea Phase III Clinical Trial
National Heart, Lung, and Blood Institute · N01
Contact PI · $479.1K · University of Miami School of Medicine
2000–2009
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $20.3K · Medical University of South Carolina
2004–2006
Pediatric Oncology Group--the Carolinas Consortium
National Cancer Institute · U10
Contact PI · $111.7K · Medical University of South Carolina
1996–2002

Clinical trials

Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia
Principal investigator · Completed · Phase 3
National Heart, Lung, and Blood Institute (NHLBI)
2000–2009
Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL
Study chair · Completed · Phase 1
Julio Barredo, MD
2019–2022
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
Study chair · Completed · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2011–2017
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Study chair · Completed · Phase 1
Therapeutic Advances in Childhood Leukemia Consortium
2011